Astraveus is developing the next generation of cell and gene therapy (CGT) manufacturing solutions.
Astraveus has raised $7.4M in total funding. The most recent round was Debt Financing. The last funding was announced in December 2024.
Astraveus's investors include Bpifrance, AdBio partners, Johnson & Johnson Innovation, EISMEA, M Ventures.
Astraveus is headquartered in Paris, France.
Astraveus is developing the next generation of cell and gene therapy (CGT) manufacturing solutions.
Astraveus is at the Debt Financing stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Astraveus — Funding & Investors." VCBacked, December 19, 2024, https://www.vcbacked.co/company/astraveus. Accessed August 15, 2026.
VCBacked. (2024). Astraveus — Funding & Investors. Retrieved August 15, 2026, from https://www.vcbacked.co/company/astraveus
{{cite web |title=Astraveus — Funding & Investors |url=https://www.vcbacked.co/company/astraveus |website=VCBacked |access-date=August 15, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated